<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2024-5862</article-id><article-id custom-type="edn" pub-id-type="custom">PCBUKX</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-5862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТАБОЛИЧЕСКОЕ ЗДОРОВЬЕ</subject></subj-group></article-categories><title-group><article-title>Маскированная неконтролируемая артериальная гипертония у пациентов с нарушением углеводного обмена</article-title><trans-title-group xml:lang="en"><trans-title>Masked uncontrolled hypertension in patients with impaired carbohydrate metabolism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4431-4961</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назарова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Виолетта Владимировна Назарова — врач-терапевт</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">violetta.nazarova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6233-7202</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антропова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Antropova</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Николаевна Антропова — профессор кафедры факультетской терапии и профессиональных болезней</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">antropovaon@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6845-6173</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Владимировна Осипова — зав. кафедрой факультетской терапии и профессиональных болезней</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">i.v.osipova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8639-5749</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Журавлева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhuravleva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алена Николаевна Журавлева — врач-терапевт, клинический фармаколог, зам. главного врача по медицинской части</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">alinagur@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6517-9880</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марина Ивановна Семенова — студентка</p><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">antropovaon@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ЧУЗ Клиническая больница "РЖД-Медицина"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Railways-Medicine Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО Алтайский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>05</day><month>04</month><year>2024</year></pub-date><volume>29</volume><issue>5</issue><fpage>5862</fpage><lpage>5862</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Назарова В.В., Антропова О.Н., Осипова И.В., Журавлева А.Н., Семенова М.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Назарова В.В., Антропова О.Н., Осипова И.В., Журавлева А.Н., Семенова М.И.</copyright-holder><copyright-holder xml:lang="en">Nazarova V.V., Antropova O.N., Osipova I.V., Zhuravleva A.N., Semenova M.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/5862">https://russjcardiol.elpub.ru/jour/article/view/5862</self-uri><abstract><sec><title>Цель</title><p>Цель:  установить частоту маскированной неконтролируемой артериальной гипертонии (МНАГ) у пациентов с сахарным диабетом (СД) или нарушением толерантности к глюкозе (НТГ) и определить ее клинико-гемодинамические особенности.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: В исследовании участвовало 87 пациентов, получавщий регулярную гипотензивную терапию АГ и имеющих установленный СД или НТГ. Средний возраст больных, 62,6±9,9 года, из них 51,7% женщины, 48,3% - мужчины. С диагнозом СД 2 типа - 77,7%,  НТГ – 22,8% больных. Для суточного мониторирования АД использовался BpLAB (ООО «Петр Телегин»), определялось АД на плечевой артерии и показатели центрального АД в аорте. Проводился анализ факторов риска, оценивалось состояние органов мишеней. Обработка полученных результатов проводилась с применением пакета прикладных программ Excel Microsoft Office 2007, пакета прикладных программ Statistica 6,0 и 10,0 компании StatSoft, Inc (США).</p></sec><sec><title>Результаты</title><p>Результаты: Неконтролируемую АГ имели 59,8%,  МНАГ - 18,4% и контролируемую АГ-  21,8% пациентов. Среднедневное и средненочное САД  у пациентов с МНАГ и  неконтролируемой АГ были сопоставимы. У пациентов с контролируемой  АГ по сравнению с МНАГ имелись меньшие значения среднего АД на аорте в дневные и ночные часы на 27,1% (р&lt;0,01) и 16,8% (р&lt;0,01) соответственно. Показатели АД на аорте были сопоставимы у лиц с МНАГ и неконтролируемой АГ. Бессимптомная гиперурикемия чаще имелась у пациентов с неконтролируемой АГ по сравнению с МНАГ и контролируемой АГ на 29,3% и 41,8% соответственно. При МНАГ по сравнению с контролируемой АГ выявлена большая частота перенесенного инсульта на 18,8%, снижения скорости клубочковой фильтрации&lt;60 мл/мин – на 17,5%, альбуминурии – на 18,8%, гипертрофии левого желудочка – в 2,6 раза.</p></sec><sec><title>Заключение</title><p>Заключение: Только 41,2% больных с СД и предиабетом достигают целевого уровня офисного АД, каждый второй из этих пациентов имеет МНАГ. МНАГ по сравнению с контролируемой АГ характеризуется большей частотой перенесенного инсульта, поражения почек (снижения СКФ&lt;60 мл/мин и альбуминурия) и сердца (гипертрофии левого желудочка).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To establish the prevalence of masked uncontrolled hypertension (HTN) (MUH) in patients with diabetes or impaired glucose tolerance (IGT) and determine its clinical and hemodynamic characteristics.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study involved 87 patients who received regular antihypertensive therapy for hypertension and had established diabetes or IGT. The mean age of patients was 62,6±9,9 years, of which 51,7% were women, 48,3% — men. Type 2 diabetes was revealed in 77,7%, IGT — 22,8% of patients. For 24-hour blood pressure monitoring, BpLAB system (OOO Petr Telegin) was used; blood pressure (BP) was determined in the brachial artery, central blood pressure — in the aorta. We analyzed risk factors and target organ damage. The results were processed using the Excel Microsoft Office 2007 package and the Statistica 6.0 and 10.0 package from StatSoft, Inc (USA).</p></sec><sec><title>Results</title><p>Results. Uncontrolled hypertension was revealed in 59,8%, MUH — in 18,4%, controlled HTN — 21,8% of patients. Mean daytime and mean nighttime systolic BP in patients with MUH and uncontrolled HTN were comparable. Patients with controlled hypertension compared with MUH had lower mean day- and nighttime aortic BP by 27,1% (p&lt;0,01) and 16,8% (p&lt;0,01), respectively. Aortic BP was comparable in individuals with MUH and uncontrolled HTN. Asymptomatic hyperuricemia was more common in patients with uncontrolled HTN compared with MUH and controlled hypertension by 29,3% and 41,8%, respectively. With MUH, compared with controlled HTN, we revealed a higher incidence of stroke by 18,8%, a decrease in glomerular filtration rate &lt;60 ml/min by 17,5%, albuminuria by 18,8%, left ventricular hypertrophy by 2,6 times.</p></sec><sec><title>Conclusion</title><p>Conclusion. Only 41,2% of patients with diabetes and prediabetes achieve the target office BP level, while every second of these patients has MUH. MUH, compared with controlled HTN, is characterized by a higher incidence of stroke, kidney (decrease in glomerular filtration rate &lt;60 ml/min and albuminuria) and heart damage (left ventricular hypertrophy).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>маскированная артериальная гипертензия</kwd><kwd>нарушение углеводного обмена</kwd><kwd>факторы риска</kwd><kwd>поражение органов-мишеней.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>masked hypertension</kwd><kwd>carbohydrate metabolism disorders</kwd><kwd>risk factors</kwd><kwd>target organ damage</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;75(2):285-92. doi:10.1161/HYPERTENSIONAHA.119.14240.</mixed-citation><mixed-citation xml:lang="en">Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;75(2):285-92. doi:10.1161/HYPERTENSIONAHA.119.14240.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-80. doi:10.1016/S0140-6736(21)01330-1.</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-80. doi:10.1016/S0140-6736(21)01330-1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гельцер Б. И., Котельников В. Н., Ветрова О. О. и др. Маскированная артериальная гипертензия: распространенность, патофизиологические детерминанты и клиническое значение. Российский кардиологический журнал. 2019;(9):92-8. doi:10.15829/1560-4071-2019-9-92-98.</mixed-citation><mixed-citation xml:lang="en">Geltser ВI, Kotelnikov VN, Vetrova ОО, et al. Masked arterial hypertension: prevalence, pathophysiological determinants and clinical significance. Russian Journal of Cardiology. 2019;(9):92-8. (In Russ.). doi:10.15829/1560-4071-2019-9-92-98.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гельцер Б. И., Шахгельдян К. И., Котельников В. Н. и др. Фенотипирование "маскированной" артериальной гипертензии по результатам кластеризации данных суточного мониторирования артериального давления. Российский кардиологический журнал. 2020;25(3):3286. doi:10.15829/1560-4071-2020-3-3286.</mixed-citation><mixed-citation xml:lang="en">Geltser ВI, Shahgeldyan KI, Kotelnikov VN, et al. Phenotyping of "masked" arterial hypertension based on the results of clustering data from 24-hour blood pressure monitoring. Russian Journal of Cardiology. 2020;25(3):3286. (In Russ.). doi:10.15829/1560-4071-2020-3-3286.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sheppard JP, Fletcher B, Gill P, et al. Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis. Am J Hypertens. 2016;29(5):614-25. doi:10.1093/ajh/hpv157.</mixed-citation><mixed-citation xml:lang="en">Sheppard JP, Fletcher B, Gill P, et al. Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis. Am J Hypertens. 2016;29(5):614-25. doi:10.1093/ajh/hpv157.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чернявина А. И., Сюзева Н. М. Предикторы развития маскированной ночной артериальной гипертензии у леченых пациентов низкого и умеренного сердечно-сосудистого риска. Артериальная гипертензия. 2022;28(4):376-85. doi:10.18705/1607-419X-2022-28-4-376-385.</mixed-citation><mixed-citation xml:lang="en">Chernyavina AI, Syuzeva NM. Predictors of the development of masked nocturnal hypertension in treated patients of low and moderate cardiovascular risk. "Arterial'naya Gipertenziya" ("Arterial Hypertension"). 2022;28(4):376-85. (In Russ.). doi:10.18705/1607-419X-2022-28-4-376-385.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Holanger M, Kjeldsen SE, Jamerson K, et al. HOT Study investigators. Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study. Blood Press. 2021;30(1):51-9. doi:10.1080/08037051.2020.1787815.</mixed-citation><mixed-citation xml:lang="en">Holanger M, Kjeldsen SE, Jamerson K, et al. HOT Study investigators. Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study. Blood Press. 2021;30(1):51-9. doi:10.1080/08037051.2020.1787815.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui M, Judd EK, Dudenbostel T, et al. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence. Hypertension. 2019;74(3):652-9. doi:10.1161/HYPERTENSIONAHA.119.13258.</mixed-citation><mixed-citation xml:lang="en">Siddiqui M, Judd EK, Dudenbostel T, et al. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence. Hypertension. 2019;74(3):652-9. doi:10.1161/HYPERTENSIONAHA.119.13258.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality. N Engl J Med. 2018;378(16):1509-20. doi:10.1056/NEJMoa1712231.</mixed-citation><mixed-citation xml:lang="en">Banegas JR, Ruilope LM, de la Sierra A, et al. Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality. N Engl J Med. 2018;378(16):1509-20. doi:10.1056/NEJMoa1712231.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hung MH, Shih LC, Wang YC, et al. Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning. Front Cardiovasc Med. 2021;8:778306. doi:10.3389/fcvm.2021.778306.</mixed-citation><mixed-citation xml:lang="en">Hung MH, Shih LC, Wang YC, et al. Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning. Front Cardiovasc Med. 2021;8:778306. doi:10.3389/fcvm.2021.778306.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Thakkar HV, Pope A, Anpalahan M. Masked Hypertension: A Systematic Review. Heart Lung Circ. 2020;29(1):102-11. doi:10.1016/j.hlc.2019.08.006.</mixed-citation><mixed-citation xml:lang="en">Thakkar HV, Pope A, Anpalahan M. Masked Hypertension: A Systematic Review. Heart Lung Circ. 2020;29(1):102-11. doi:10.1016/j.hlc.2019.08.006.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman M, Wang X, Bundy JD, et al. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2020;31(11):2609-21. doi:10.1681/ASN.2020030236.</mixed-citation><mixed-citation xml:lang="en">Rahman M, Wang X, Bundy JD, et al. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2020;31(11):2609-21. doi:10.1681/ASN.2020030236.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lamarche F, Agharazii M, Madore F, et al. Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure: A Prospective Study. Hypertension. 2021;77(2):319-27. doi:10.1161/HYPERTENSIONAHA.120.16163.</mixed-citation><mixed-citation xml:lang="en">Lamarche F, Agharazii M, Madore F, et al. Prediction of Cardiovascular Events by Type I Central Systolic Blood Pressure: A Prospective Study. Hypertension. 2021;77(2):319-27. doi:10.1161/HYPERTENSIONAHA.120.16163.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yu S, Xiong J, Lu Y, et al. The prevalence of central hypertension defined by a central blood pressure type I device and its association with target organ damage in the community-dwelling elderly Chinese: The Northern Shanghai Study. J Am Soc Hypertens. 2018;12(3):211-9. doi:10.1016/j.jash.2017.12.013.</mixed-citation><mixed-citation xml:lang="en">Yu S, Xiong J, Lu Y, et al. The prevalence of central hypertension defined by a central blood pressure type I device and its association with target organ damage in the community-dwelling elderly Chinese: The Northern Shanghai Study. J Am Soc Hypertens. 2018;12(3):211-9. doi:10.1016/j.jash.2017.12.013.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
